MARKET

MRNA

MRNA

Moderna
NASDAQ
41.01
+0.14
+0.34%
After Hours: 40.82 -0.19 -0.46% 19:57 02/06 EST
OPEN
41.18
PREV CLOSE
40.87
HIGH
41.49
LOW
39.50
VOLUME
8.34M
TURNOVER
--
52 WEEK HIGH
55.20
52 WEEK LOW
22.28
MARKET CAP
16.02B
P/E (TTM)
-5.0952
1D
5D
1M
3M
1Y
5Y
1D
Why Moderna (MRNA) Is Down 6.9% After Judge Lets US$5 Billion Patent Lawsuit Proceed
Simply Wall St · 9h ago
Arbutus Biopharma Announces U.S. District Court For The District of Delaware Issues Memorandum, Order In Litigation Filed Co. Against Moderna Over Patent Infringement
Benzinga · 14h ago
ARBUTUS BIOPHARMA CORP - U.S. COURT ISSUES MEMORANDUM IN ARBUTUS VS. MODERNA CASE - SEC FILING
Reuters · 14h ago
Catalyst Watch: Crypto swings, FedEx investor event, and Super Bowl bets
Seeking Alpha · 15h ago
Mixed options sentiment in Moderna with shares down 1.52%
TipRanks · 17h ago
Vanguard S&P 500 ETF (VOO) Daily Update, 2/6/2026
TipRanks · 21h ago
RSP, SNDK, WDC, MRNA: Large Outflows Detected at ETF
NASDAQ · 1d ago
Interesting MRNA Put And Call Options For March 27th
NASDAQ · 1d ago
More
About MRNA
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.